ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Human Coagulation Factor VIII Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-28D484
Home | Market Reports | Health| Pharmacy
Global Human Coagulation Factor VIII Market Insights and Forecast to 2028
BUY CHAPTERS

Global Human Coagulation Factor VIII Market Research Report 2025

Code: QYRE-Auto-28D484
Report
May 2025
Pages:94
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Bayer
CSL Limited
Pfizer Inc
Greencross
Kedrion S p A
BPL
Hualan Bio
RAAS
Grifols
Octapharma
Grifols S A
Biogen
Octapharma AG
NovoNordisk
Shire (Baxter)

Human Coagulation Factor VIII Market Size

The global market for Human Coagulation Factor VIII was valued at US$ 11550 million in the year 2024 and is projected to reach a revised size of US$ 17610 million by 2031, growing at a CAGR of 6.3% during the forecast period.

Human Coagulation Factor VIII Market

Human Coagulation Factor VIII Market

Human Coagulation Factor VIII is an essential blood-clotting protein, also known as anti-hemophilic factor (AHF). In humans, factor VIII is encoded by the F8 gene, defects in this gene results in hemophilia A. Human Coagulation Factor VIII concentrated from donated blood plasma (Aafact or Alphanate, Monoclate-P®), or alternatively recombinant Human Coagulation Factor VIII can be given to hemophiliacs to restore hemostasis.
Global Human Coagulation Factor VIII key players include Baxter, Bayer, CSL, Pfizer, Biogen, etc. Global top five manufacturers hold a share about 80%. North America is the largest market, with a share about 60%, followed by Europe, with a share about 30 percent. In terms of product, Recombinant Factor VIII is the largest segment, with a share about 65%. And in terms of application, the largest application is Hemophilia A, followed by Spontanous / Trauma, Surgical, etc.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Human Coagulation Factor VIII, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Coagulation Factor VIII.
The Human Coagulation Factor VIII market size, estimations, and forecasts are provided in terms of sales volume (K Bottles) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Human Coagulation Factor VIII market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Human Coagulation Factor VIII manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Human Coagulation Factor VIII Market Report

Report Metric Details
Report Name Human Coagulation Factor VIII Market
Accounted market size in year US$ 11550 million
Forecasted market size in 2031 US$ 17610 million
CAGR 6.3%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Recombinant Factor VIII
  • Plasma-derived Factor VIII
Segment by Application
  • Hemophilia A
  • Spontanous / Trauma
  • Surgical
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Shire (Baxter), Bayer, CSL, Pfizer, Grifols, Biogen, Octapharma, NovoNordisk, Greencross, Kedrion, BPL, Hualan Bio, RAAS
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Human Coagulation Factor VIII manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Human Coagulation Factor VIII in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Human Coagulation Factor VIII Market growing?

Ans: The Human Coagulation Factor VIII Market witnessing a CAGR of 6.3% during the forecast period 2025-2031.

What is the Human Coagulation Factor VIII Market size in 2031?

Ans: The Human Coagulation Factor VIII Market size in 2031 will be US$ 17610 million.

What is the market share of major companies in Human Coagulation Factor VIII Market?

Ans: Global top five manufacturers hold a share about 80%.

What is the Human Coagulation Factor VIII Market share by region?

Ans: North America is the largest market, with a share about 60%, followed by Europe, with a share about 30 percent.

What is the Human Coagulation Factor VIII Market share by type?

Ans: In terms of product, Recombinant Factor VIII is the largest segment, with a share about 65%.

Who are the main players in the Human Coagulation Factor VIII Market report?

Ans: The main players in the Human Coagulation Factor VIII Market are Shire (Baxter), Bayer, CSL, Pfizer, Grifols, Biogen, Octapharma, NovoNordisk, Greencross, Kedrion, BPL, Hualan Bio, RAAS

What are the Application segmentation covered in the Human Coagulation Factor VIII Market report?

Ans: The Applications covered in the Human Coagulation Factor VIII Market report are Hemophilia A, Spontanous / Trauma, Surgical, Other

What are the Type segmentation covered in the Human Coagulation Factor VIII Market report?

Ans: The Types covered in the Human Coagulation Factor VIII Market report are Recombinant Factor VIII, Plasma-derived Factor VIII

Recommended Reports

Coagulation Factors

Hemostasis Products

Coagulation Analyzers

1 Human Coagulation Factor VIII Market Overview
1.1 Product Definition
1.2 Human Coagulation Factor VIII by Type
1.2.1 Global Human Coagulation Factor VIII Market Value Comparison by Type (2024 VS 2031)
1.2.2 Recombinant Factor VIII
1.2.3 Plasma-derived Factor VIII
1.3 Human Coagulation Factor VIII by Application
1.3.1 Global Human Coagulation Factor VIII Market Value by Application (2024 VS 2031)
1.3.2 Hemophilia A
1.3.3 Spontanous / Trauma
1.3.4 Surgical
1.3.5 Other
1.4 Global Human Coagulation Factor VIII Market Size Estimates and Forecasts
1.4.1 Global Human Coagulation Factor VIII Revenue 2020-2031
1.4.2 Global Human Coagulation Factor VIII Sales 2020-2031
1.4.3 Global Human Coagulation Factor VIII Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Human Coagulation Factor VIII Market Competition by Manufacturers
2.1 Global Human Coagulation Factor VIII Sales Market Share by Manufacturers (2020-2025)
2.2 Global Human Coagulation Factor VIII Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Human Coagulation Factor VIII Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Human Coagulation Factor VIII, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Human Coagulation Factor VIII, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Human Coagulation Factor VIII, Product Type & Application
2.7 Global Key Manufacturers of Human Coagulation Factor VIII, Date of Enter into This Industry
2.8 Global Human Coagulation Factor VIII Market Competitive Situation and Trends
2.8.1 Global Human Coagulation Factor VIII Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Human Coagulation Factor VIII Players Market Share by Revenue
2.8.3 Global Human Coagulation Factor VIII Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Human Coagulation Factor VIII Market Scenario by Region
3.1 Global Human Coagulation Factor VIII Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Human Coagulation Factor VIII Sales by Region: 2020-2031
3.2.1 Global Human Coagulation Factor VIII Sales by Region: 2020-2025
3.2.2 Global Human Coagulation Factor VIII Sales by Region: 2026-2031
3.3 Global Human Coagulation Factor VIII Revenue by Region: 2020-2031
3.3.1 Global Human Coagulation Factor VIII Revenue by Region: 2020-2025
3.3.2 Global Human Coagulation Factor VIII Revenue by Region: 2026-2031
3.4 North America Human Coagulation Factor VIII Market Facts & Figures by Country
3.4.1 North America Human Coagulation Factor VIII Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Human Coagulation Factor VIII Sales by Country (2020-2031)
3.4.3 North America Human Coagulation Factor VIII Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Human Coagulation Factor VIII Market Facts & Figures by Country
3.5.1 Europe Human Coagulation Factor VIII Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Human Coagulation Factor VIII Sales by Country (2020-2031)
3.5.3 Europe Human Coagulation Factor VIII Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Human Coagulation Factor VIII Market Facts & Figures by Region
3.6.1 Asia Pacific Human Coagulation Factor VIII Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Human Coagulation Factor VIII Sales by Region (2020-2031)
3.6.3 Asia Pacific Human Coagulation Factor VIII Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Human Coagulation Factor VIII Market Facts & Figures by Country
3.7.1 Latin America Human Coagulation Factor VIII Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Human Coagulation Factor VIII Sales by Country (2020-2031)
3.7.3 Latin America Human Coagulation Factor VIII Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Human Coagulation Factor VIII Market Facts & Figures by Country
3.8.1 Middle East and Africa Human Coagulation Factor VIII Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Human Coagulation Factor VIII Sales by Country (2020-2031)
3.8.3 Middle East and Africa Human Coagulation Factor VIII Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Human Coagulation Factor VIII Sales by Type (2020-2031)
4.1.1 Global Human Coagulation Factor VIII Sales by Type (2020-2025)
4.1.2 Global Human Coagulation Factor VIII Sales by Type (2026-2031)
4.1.3 Global Human Coagulation Factor VIII Sales Market Share by Type (2020-2031)
4.2 Global Human Coagulation Factor VIII Revenue by Type (2020-2031)
4.2.1 Global Human Coagulation Factor VIII Revenue by Type (2020-2025)
4.2.2 Global Human Coagulation Factor VIII Revenue by Type (2026-2031)
4.2.3 Global Human Coagulation Factor VIII Revenue Market Share by Type (2020-2031)
4.3 Global Human Coagulation Factor VIII Price by Type (2020-2031)
5 Segment by Application
5.1 Global Human Coagulation Factor VIII Sales by Application (2020-2031)
5.1.1 Global Human Coagulation Factor VIII Sales by Application (2020-2025)
5.1.2 Global Human Coagulation Factor VIII Sales by Application (2026-2031)
5.1.3 Global Human Coagulation Factor VIII Sales Market Share by Application (2020-2031)
5.2 Global Human Coagulation Factor VIII Revenue by Application (2020-2031)
5.2.1 Global Human Coagulation Factor VIII Revenue by Application (2020-2025)
5.2.2 Global Human Coagulation Factor VIII Revenue by Application (2026-2031)
5.2.3 Global Human Coagulation Factor VIII Revenue Market Share by Application (2020-2031)
5.3 Global Human Coagulation Factor VIII Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Shire (Baxter)
6.1.1 Shire (Baxter) Company Information
6.1.2 Shire (Baxter) Description and Business Overview
6.1.3 Shire (Baxter) Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Shire (Baxter) Human Coagulation Factor VIII Product Portfolio
6.1.5 Shire (Baxter) Recent Developments/Updates
6.2 Bayer
6.2.1 Bayer Company Information
6.2.2 Bayer Description and Business Overview
6.2.3 Bayer Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Bayer Human Coagulation Factor VIII Product Portfolio
6.2.5 Bayer Recent Developments/Updates
6.3 CSL
6.3.1 CSL Company Information
6.3.2 CSL Description and Business Overview
6.3.3 CSL Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2020-2025)
6.3.4 CSL Human Coagulation Factor VIII Product Portfolio
6.3.5 CSL Recent Developments/Updates
6.4 Pfizer
6.4.1 Pfizer Company Information
6.4.2 Pfizer Description and Business Overview
6.4.3 Pfizer Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Pfizer Human Coagulation Factor VIII Product Portfolio
6.4.5 Pfizer Recent Developments/Updates
6.5 Grifols
6.5.1 Grifols Company Information
6.5.2 Grifols Description and Business Overview
6.5.3 Grifols Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Grifols Human Coagulation Factor VIII Product Portfolio
6.5.5 Grifols Recent Developments/Updates
6.6 Biogen
6.6.1 Biogen Company Information
6.6.2 Biogen Description and Business Overview
6.6.3 Biogen Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Biogen Human Coagulation Factor VIII Product Portfolio
6.6.5 Biogen Recent Developments/Updates
6.7 Octapharma
6.7.1 Octapharma Company Information
6.7.2 Octapharma Description and Business Overview
6.7.3 Octapharma Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Octapharma Human Coagulation Factor VIII Product Portfolio
6.7.5 Octapharma Recent Developments/Updates
6.8 NovoNordisk
6.8.1 NovoNordisk Company Information
6.8.2 NovoNordisk Description and Business Overview
6.8.3 NovoNordisk Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2020-2025)
6.8.4 NovoNordisk Human Coagulation Factor VIII Product Portfolio
6.8.5 NovoNordisk Recent Developments/Updates
6.9 Greencross
6.9.1 Greencross Company Information
6.9.2 Greencross Description and Business Overview
6.9.3 Greencross Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Greencross Human Coagulation Factor VIII Product Portfolio
6.9.5 Greencross Recent Developments/Updates
6.10 Kedrion
6.10.1 Kedrion Company Information
6.10.2 Kedrion Description and Business Overview
6.10.3 Kedrion Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Kedrion Human Coagulation Factor VIII Product Portfolio
6.10.5 Kedrion Recent Developments/Updates
6.11 BPL
6.11.1 BPL Company Information
6.11.2 BPL Description and Business Overview
6.11.3 BPL Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2020-2025)
6.11.4 BPL Human Coagulation Factor VIII Product Portfolio
6.11.5 BPL Recent Developments/Updates
6.12 Hualan Bio
6.12.1 Hualan Bio Company Information
6.12.2 Hualan Bio Description and Business Overview
6.12.3 Hualan Bio Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Hualan Bio Human Coagulation Factor VIII Product Portfolio
6.12.5 Hualan Bio Recent Developments/Updates
6.13 RAAS
6.13.1 RAAS Company Information
6.13.2 RAAS Description and Business Overview
6.13.3 RAAS Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2020-2025)
6.13.4 RAAS Human Coagulation Factor VIII Product Portfolio
6.13.5 RAAS Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Human Coagulation Factor VIII Industry Chain Analysis
7.2 Human Coagulation Factor VIII Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Human Coagulation Factor VIII Production Mode & Process Analysis
7.4 Human Coagulation Factor VIII Sales and Marketing
7.4.1 Human Coagulation Factor VIII Sales Channels
7.4.2 Human Coagulation Factor VIII Distributors
7.5 Human Coagulation Factor VIII Customer Analysis
8 Human Coagulation Factor VIII Market Dynamics
8.1 Human Coagulation Factor VIII Industry Trends
8.2 Human Coagulation Factor VIII Market Drivers
8.3 Human Coagulation Factor VIII Market Challenges
8.4 Human Coagulation Factor VIII Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Bayer
CSL Limited
Pfizer Inc
Greencross
Kedrion S p A
BPL
Hualan Bio
RAAS
Grifols
Octapharma
Grifols S A
Biogen
Octapharma AG
NovoNordisk
Shire (Baxter)
List of Tables
 Table 1. Global Human Coagulation Factor VIII Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Human Coagulation Factor VIII Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Human Coagulation Factor VIII Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Human Coagulation Factor VIII Sales (K Bottles) of Key Manufacturers (2020-2025)
 Table 5. Global Human Coagulation Factor VIII Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Human Coagulation Factor VIII Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Human Coagulation Factor VIII Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Human Coagulation Factor VIII Average Price (USD/Bottle) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Human Coagulation Factor VIII, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Human Coagulation Factor VIII, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Human Coagulation Factor VIII, Product Type & Application
 Table 12. Global Key Manufacturers of Human Coagulation Factor VIII, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Human Coagulation Factor VIII by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Coagulation Factor VIII as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Human Coagulation Factor VIII Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Human Coagulation Factor VIII Sales by Region (2020-2025) & (K Bottles)
 Table 18. Global Human Coagulation Factor VIII Sales Market Share by Region (2020-2025)
 Table 19. Global Human Coagulation Factor VIII Sales by Region (2026-2031) & (K Bottles)
 Table 20. Global Human Coagulation Factor VIII Sales Market Share by Region (2026-2031)
 Table 21. Global Human Coagulation Factor VIII Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Human Coagulation Factor VIII Revenue Market Share by Region (2020-2025)
 Table 23. Global Human Coagulation Factor VIII Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Human Coagulation Factor VIII Revenue Market Share by Region (2026-2031)
 Table 25. North America Human Coagulation Factor VIII Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Human Coagulation Factor VIII Sales by Country (2020-2025) & (K Bottles)
 Table 27. North America Human Coagulation Factor VIII Sales by Country (2026-2031) & (K Bottles)
 Table 28. North America Human Coagulation Factor VIII Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Human Coagulation Factor VIII Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Human Coagulation Factor VIII Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Human Coagulation Factor VIII Sales by Country (2020-2025) & (K Bottles)
 Table 32. Europe Human Coagulation Factor VIII Sales by Country (2026-2031) & (K Bottles)
 Table 33. Europe Human Coagulation Factor VIII Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Human Coagulation Factor VIII Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Human Coagulation Factor VIII Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Human Coagulation Factor VIII Sales by Region (2020-2025) & (K Bottles)
 Table 37. Asia Pacific Human Coagulation Factor VIII Sales by Region (2026-2031) & (K Bottles)
 Table 38. Asia Pacific Human Coagulation Factor VIII Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Human Coagulation Factor VIII Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Human Coagulation Factor VIII Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Human Coagulation Factor VIII Sales by Country (2020-2025) & (K Bottles)
 Table 42. Latin America Human Coagulation Factor VIII Sales by Country (2026-2031) & (K Bottles)
 Table 43. Latin America Human Coagulation Factor VIII Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Human Coagulation Factor VIII Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Human Coagulation Factor VIII Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Human Coagulation Factor VIII Sales by Country (2020-2025) & (K Bottles)
 Table 47. Middle East and Africa Human Coagulation Factor VIII Sales by Country (2026-2031) & (K Bottles)
 Table 48. Middle East and Africa Human Coagulation Factor VIII Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Human Coagulation Factor VIII Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Human Coagulation Factor VIII Sales (K Bottles) by Type (2020-2025)
 Table 51. Global Human Coagulation Factor VIII Sales (K Bottles) by Type (2026-2031)
 Table 52. Global Human Coagulation Factor VIII Sales Market Share by Type (2020-2025)
 Table 53. Global Human Coagulation Factor VIII Sales Market Share by Type (2026-2031)
 Table 54. Global Human Coagulation Factor VIII Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Human Coagulation Factor VIII Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Human Coagulation Factor VIII Revenue Market Share by Type (2020-2025)
 Table 57. Global Human Coagulation Factor VIII Revenue Market Share by Type (2026-2031)
 Table 58. Global Human Coagulation Factor VIII Price (USD/Bottle) by Type (2020-2025)
 Table 59. Global Human Coagulation Factor VIII Price (USD/Bottle) by Type (2026-2031)
 Table 60. Global Human Coagulation Factor VIII Sales (K Bottles) by Application (2020-2025)
 Table 61. Global Human Coagulation Factor VIII Sales (K Bottles) by Application (2026-2031)
 Table 62. Global Human Coagulation Factor VIII Sales Market Share by Application (2020-2025)
 Table 63. Global Human Coagulation Factor VIII Sales Market Share by Application (2026-2031)
 Table 64. Global Human Coagulation Factor VIII Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Human Coagulation Factor VIII Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Human Coagulation Factor VIII Revenue Market Share by Application (2020-2025)
 Table 67. Global Human Coagulation Factor VIII Revenue Market Share by Application (2026-2031)
 Table 68. Global Human Coagulation Factor VIII Price (USD/Bottle) by Application (2020-2025)
 Table 69. Global Human Coagulation Factor VIII Price (USD/Bottle) by Application (2026-2031)
 Table 70. Shire (Baxter) Company Information
 Table 71. Shire (Baxter) Description and Business Overview
 Table 72. Shire (Baxter) Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2020-2025)
 Table 73. Shire (Baxter) Human Coagulation Factor VIII Product
 Table 74. Shire (Baxter) Recent Developments/Updates
 Table 75. Bayer Company Information
 Table 76. Bayer Description and Business Overview
 Table 77. Bayer Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2020-2025)
 Table 78. Bayer Human Coagulation Factor VIII Product
 Table 79. Bayer Recent Developments/Updates
 Table 80. CSL Company Information
 Table 81. CSL Description and Business Overview
 Table 82. CSL Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2020-2025)
 Table 83. CSL Human Coagulation Factor VIII Product
 Table 84. CSL Recent Developments/Updates
 Table 85. Pfizer Company Information
 Table 86. Pfizer Description and Business Overview
 Table 87. Pfizer Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2020-2025)
 Table 88. Pfizer Human Coagulation Factor VIII Product
 Table 89. Pfizer Recent Developments/Updates
 Table 90. Grifols Company Information
 Table 91. Grifols Description and Business Overview
 Table 92. Grifols Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2020-2025)
 Table 93. Grifols Human Coagulation Factor VIII Product
 Table 94. Grifols Recent Developments/Updates
 Table 95. Biogen Company Information
 Table 96. Biogen Description and Business Overview
 Table 97. Biogen Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2020-2025)
 Table 98. Biogen Human Coagulation Factor VIII Product
 Table 99. Biogen Recent Developments/Updates
 Table 100. Octapharma Company Information
 Table 101. Octapharma Description and Business Overview
 Table 102. Octapharma Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2020-2025)
 Table 103. Octapharma Human Coagulation Factor VIII Product
 Table 104. Octapharma Recent Developments/Updates
 Table 105. NovoNordisk Company Information
 Table 106. NovoNordisk Description and Business Overview
 Table 107. NovoNordisk Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2020-2025)
 Table 108. NovoNordisk Human Coagulation Factor VIII Product
 Table 109. NovoNordisk Recent Developments/Updates
 Table 110. Greencross Company Information
 Table 111. Greencross Description and Business Overview
 Table 112. Greencross Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2020-2025)
 Table 113. Greencross Human Coagulation Factor VIII Product
 Table 114. Greencross Recent Developments/Updates
 Table 115. Kedrion Company Information
 Table 116. Kedrion Description and Business Overview
 Table 117. Kedrion Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2020-2025)
 Table 118. Kedrion Human Coagulation Factor VIII Product
 Table 119. Kedrion Recent Developments/Updates
 Table 120. BPL Company Information
 Table 121. BPL Description and Business Overview
 Table 122. BPL Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2020-2025)
 Table 123. BPL Human Coagulation Factor VIII Product
 Table 124. BPL Recent Developments/Updates
 Table 125. Hualan Bio Company Information
 Table 126. Hualan Bio Description and Business Overview
 Table 127. Hualan Bio Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2020-2025)
 Table 128. Hualan Bio Human Coagulation Factor VIII Product
 Table 129. Hualan Bio Recent Developments/Updates
 Table 130. RAAS Company Information
 Table 131. RAAS Description and Business Overview
 Table 132. RAAS Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2020-2025)
 Table 133. RAAS Human Coagulation Factor VIII Product
 Table 134. RAAS Recent Developments/Updates
 Table 135. Key Raw Materials Lists
 Table 136. Raw Materials Key Suppliers Lists
 Table 137. Human Coagulation Factor VIII Distributors List
 Table 138. Human Coagulation Factor VIII Customers List
 Table 139. Human Coagulation Factor VIII Market Trends
 Table 140. Human Coagulation Factor VIII Market Drivers
 Table 141. Human Coagulation Factor VIII Market Challenges
 Table 142. Human Coagulation Factor VIII Market Restraints
 Table 143. Research Programs/Design for This Report
 Table 144. Key Data Information from Secondary Sources
 Table 145. Key Data Information from Primary Sources
 Table 146. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Human Coagulation Factor VIII
 Figure 2. Global Human Coagulation Factor VIII Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Human Coagulation Factor VIII Market Share by Type: 2024 & 2031
 Figure 4. Recombinant Factor VIII Product Picture
 Figure 5. Plasma-derived Factor VIII Product Picture
 Figure 6. Global Human Coagulation Factor VIII Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Human Coagulation Factor VIII Market Share by Application: 2024 & 2031
 Figure 8. Hemophilia A
 Figure 9. Spontanous / Trauma
 Figure 10. Surgical
 Figure 11. Other
 Figure 12. Global Human Coagulation Factor VIII Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Human Coagulation Factor VIII Market Size (2020-2031) & (US$ Million)
 Figure 14. Global Human Coagulation Factor VIII Sales (2020-2031) & (K Bottles)
 Figure 15. Global Human Coagulation Factor VIII Average Price (USD/Bottle) & (2020-2031)
 Figure 16. Human Coagulation Factor VIII Report Years Considered
 Figure 17. Human Coagulation Factor VIII Sales Share by Manufacturers in 2024
 Figure 18. Global Human Coagulation Factor VIII Revenue Share by Manufacturers in 2024
 Figure 19. Global 5 and 10 Largest Human Coagulation Factor VIII Players: Market Share by Revenue in Human Coagulation Factor VIII in 2024
 Figure 20. Human Coagulation Factor VIII Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 21. Global Human Coagulation Factor VIII Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 22. North America Human Coagulation Factor VIII Sales Market Share by Country (2020-2031)
 Figure 23. North America Human Coagulation Factor VIII Revenue Market Share by Country (2020-2031)
 Figure 24. U.S. Human Coagulation Factor VIII Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Canada Human Coagulation Factor VIII Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Europe Human Coagulation Factor VIII Sales Market Share by Country (2020-2031)
 Figure 27. Europe Human Coagulation Factor VIII Revenue Market Share by Country (2020-2031)
 Figure 28. Germany Human Coagulation Factor VIII Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. France Human Coagulation Factor VIII Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. U.K. Human Coagulation Factor VIII Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Italy Human Coagulation Factor VIII Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Russia Human Coagulation Factor VIII Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Asia Pacific Human Coagulation Factor VIII Sales Market Share by Region (2020-2031)
 Figure 34. Asia Pacific Human Coagulation Factor VIII Revenue Market Share by Region (2020-2031)
 Figure 35. China Human Coagulation Factor VIII Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Japan Human Coagulation Factor VIII Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. South Korea Human Coagulation Factor VIII Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. India Human Coagulation Factor VIII Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Australia Human Coagulation Factor VIII Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Taiwan Human Coagulation Factor VIII Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Indonesia Human Coagulation Factor VIII Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Thailand Human Coagulation Factor VIII Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Malaysia Human Coagulation Factor VIII Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Philippines Human Coagulation Factor VIII Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Latin America Human Coagulation Factor VIII Sales Market Share by Country (2020-2031)
 Figure 46. Latin America Human Coagulation Factor VIII Revenue Market Share by Country (2020-2031)
 Figure 47. Mexico Human Coagulation Factor VIII Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Brazil Human Coagulation Factor VIII Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Argentina Human Coagulation Factor VIII Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Middle East and Africa Human Coagulation Factor VIII Sales Market Share by Country (2020-2031)
 Figure 51. Middle East and Africa Human Coagulation Factor VIII Revenue Market Share by Country (2020-2031)
 Figure 52. Turkey Human Coagulation Factor VIII Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Saudi Arabia Human Coagulation Factor VIII Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. U.A.E Human Coagulation Factor VIII Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Global Sales Market Share of Human Coagulation Factor VIII by Type (2020-2031)
 Figure 56. Global Revenue Market Share of Human Coagulation Factor VIII by Type (2020-2031)
 Figure 57. Global Human Coagulation Factor VIII Price (USD/Bottle) by Type (2020-2031)
 Figure 58. Global Sales Market Share of Human Coagulation Factor VIII by Application (2020-2031)
 Figure 59. Global Revenue Market Share of Human Coagulation Factor VIII by Application (2020-2031)
 Figure 60. Global Human Coagulation Factor VIII Price (USD/Bottle) by Application (2020-2031)
 Figure 61. Human Coagulation Factor VIII Value Chain
 Figure 62. Channels of Distribution (Direct Vs Distribution)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS

Human Coagulation Factor Ⅷ Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Factor VIII Deficiency Treatment Market
Recombinant Factor VIII Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Recombinant Human Coagulation Factor VIII for Injection Market Research Report 2024
Plasma derived Factor VIII Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Recombinant Coagulation Factor Concentrate Market Research Report 2024
Recombinant Coagulation Factor Ⅷ for Injection Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Human Coagulation Factor VII Market Insights Forecast to 2030
Antihemophilic Factor Recombinant Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Recombinant Antihemophilic Factor Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Hemophilia AAV Gene Therapy Market Research Report 2024
Antihemophilic Factor Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Recombinant Antihemophilic Globulin Market Research Report 2024
Human Factor VIII Concentrate Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Hemophilia monoclonal antibody Market Research Report 2024
Global Factor IX Deficiency Treatment Market Research Report 2024
Coagulation Factors Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Coagulation Factor Concentrate Market Research Report 2025
Hemophilia Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Rare Hemophilia Factors Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions